HYLORIS PHARMACEUTIC

HYL
Real-time Quote. Real-time  - 10/18 09:46:38 am
13.95EUR +2.20%

Turn to zoom
Prev.13.6500
Open13.6000
High13.9500
Low13.6000
Volume7 157
Latest news
5d ago
5d ago
5d ago
10/08
Chart HYLORIS PHARMACEUTICALS SA
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance13,914,514,3
Spread/Res.0,72%-3,8%-2,1%
Spread/Supp.7,3%9,8%19%
Support13,012,711,7
Financials
Sales 2020 0,95 M 1,10 M 1,10 M
Net income 2020 -6,00 M -6,96 M -6,96 M
Net cash 2020 48,0 M 55,7 M 55,7 M
P/E ratio 2020 -7,98x
Yield 2020 -
Capitalization 353 M 409 M 409 M
EV / Sales 2020 321x
EV / Sales 2021 117x
Nbr of Employees -
Free-Float 41,0%
Company
Hyloris Pharmaceuticals is a Belgium-based specialty pharmaceutical company. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-10-23 Presentation

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 13,65 €
Average target price 17,25 €
Spread / Average Target 26,4%